SAVI® Brachy

TARGETED ACCELERATED PARTIAL BREAST IRRADIATION (APBI) IN JUST 2-5 DAYS* REDUCES PATIENT INTERACTIONS

SAVI Brachy offers a strut-based approach to tissue-sparing dosimetry and is designed to maximize ease of use during placement while providing unparalleled dose customization. Three-fraction treatment protocol with SAVI allows effective APBI treatment to be completed in as little as 2 days², significantly decreasing contact interactions between patients and medical staff.

Video Gallery

INTRODUCING SAVI BRACHYTHERAPY

SAVI Brachy uses thin tubes (catheters) to deliver radiation directly to the lumpectomy site. The catheters gently expand to fit the size and shape of the tumor cavity. A tiny radiation seed travels through each catheter to deliver a precise dose of radiation, customized for the exact size, shape or location of the target tissue.

Features & Benefits

How Does SAVI Brachy Work?

PLACEMENT

The SAVI Brachy applicator is gently inserted in a closed position into the tumor cavity through a small incision, a procedure that is usually done in the physician’s office.

EXPANSION

The catheters are gently expanded to conform to the shape of the cavity. This is done only once, at the beginning of treatment.

RADIATION DELIVERY

Once the catheter is in place, a radiation oncologist delivers treatment twice a day for 2-5 days. The ends of the catheters are connected to a computerized delivery system that painlessly delivers a tiny radioactive seed into each tube. The radiation source is completely removed after each treatment – no radiation remains in the body between treatments.

REMOVAL

After the last radiation treatment, the physician will close the device and remove it through the same incision into which it was originally inserted.

CLINICAL DATA

FEATURED STUDY:
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial

Overview of First Reported Results

200 patients enrolled August 2015 – August 2017

Int J Radiat Oncol Biol Phys. 2019;104(1):67-74. doi:10.1016/j.ijrobp.2018.12.050.

Download Preview >>

Objectives & Goals

Primary Objective:
Toxicity @ 2 yrs

Goal: <10% serious toxicity rate* (Grade 3 or above)
Results: Grade 3 N=3 (1.5%) N=11 upper limit

Secondary Objectives:
Cosmesis @ 2 yrs.

Goal: >80% good/excellent
Results: 97.25% good/excellent

Local control @ 3 yrs:

Goal: ≤5% recurrence
Results: 1% (Local control 99%)

Reported Conclusions

Ultrashort breast brachytherapy is dosimetrically feasible and can be delivered with excellent short-term tolerance and low toxicity.

Learn More

ADDITIONAL STUDIES

Peer Reviewed: L.E. Simon et al. (2022). Retrospective review of three-fractioned accelerated partial breast irradiation, Brachytherapy, https://doi.org/10.1016/j.brachy.2022.02.002
Download Study

Case Review: Yashar (2019). SAVI Brachytherapy with TRIUMPH-T 2-day Treatment Regimen.
Download Case Study

Peer Reviewed: Wilkinson JB, Chen PY, Wallace MF, et al. (2018). Six-Year Results From a Phase I/II Trial for Hypofractionated Accelerated Partial Breast Irradiation Using a 2-Day Dose Schedule. Am J Clin Oncol. 2018;41(10):986-991. doi:10.1097/COC.0000000000000402
https://pubmed.ncbi.nlm.nih.gov/28787281/
Preview

Peer Reviewed: Yashar C, Attai D, Butler E, et al. (2016). Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study. Brachytherapy. 2016;15(6):780-787. doi:10.1016/j.brachy.2016.07.002
https://pubmed.ncbi.nlm.nih.gov/27528591/
Preview

Peer Reviewed: Rehman S, Agarwal R, Ochoa L, et al. (2016). Prospective analysis of toxicity in patients treated with strut-adjusted volume implant for early-stage breast cancer. Brachytherapy. 2016;15(5):625-630. doi:10.1016/j.brachy.2016.04.008
https://pubmed.ncbi.nlm.nih.gov/27263058/
Preview

Peer Reviewed: Mooney KE, Altman MB, Edward S, et al. (2016). Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant. Brachytherapy. 2016;15(5):616-624. doi:10.1016/j.brachy.2016.05.002
https://pubmed.ncbi.nlm.nih.gov/27349857/
Preview

Strnad et al. (2015). 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. 2016;387(10015):229-238, Jan 16, 2016. doi:https://doi.org/10.1016/S0140-6736(15)00471-7
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00471-7/fulltext
Preview

Looking for more? Find Pre-2015 studies here >>

CONSENSUS STATEMENTS

Patient Selection Criteria PDF

Shah C, Vicini F, Shaitelman SF, et al. (2017). The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. Brachytherapy. 2018;17(1):154-170. doi:10.1016/j.brachy.2017.09.004 https://pubmed.ncbi.nlm.nih.gov/29074088/

The American Society of Breast Surgeons (2011). Consensus statement for accelerated partial breast irradiation. https://www.breastsurgeons.org/docs/statements/Consensus-Statement-for-Accelerated-Partial-Breast-Irradiation.pdf

American Society Radiation and Oncology (2016). Consensus Statement on Partial Breast Irradiation. https://www.practicalradonc.org/article/S1879-8500(16)30184-9/fulltext

Request Information

COVID-SPECIFIC SUPPORT MATERIALS

Download PDF

View Webinar Resources

Download Infographic

Ask A Question

REFERENCES

Gurdalli S, Kuske R, Quiet C. Dosimetric Comparison of Three Brachytherapy Applicators for Partial Breast Irradiation. Poster session presented at the World Congress of Brachytherapy, May 4-6, 2008.
Khan AJ, Chen PY, Yashar C, et al. Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. Int J Radiat Oncol Biol Phys. 2019;104(1):67-74. doi:10.1016/j.ijrobp.2018.12.050
Hannoun-Levi JM, Resch A, Gal J, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol. 2013;108(2):226-231. doi:10.1016/j.radonc.2013.03.026
Yashar C, Scanderbeg D, et al. Initial Clinical Experience with the Strut-Adjusted Volume Implant (SAVI) Breast Brachytherapy Device for Accelerated Partial-Breast Irradiation (APBI): First 100 Patients with More than 1 Year of Follow Up. Int J Radiat Oncol Biol Phys. 2011 Jul 1; 80(3): 765-70.
Van Limbergen E & Mazeron JJ. Breast Cancer. In Gerbaulet A, Pötter R, Mazeron J-J, Meertens H and Van Limbergen E (Eds).The GEC ESTRO Handbook of Brachytherapy. Leuven, Belgium, ACCO. 2002
Vratislav Strnad, MD, Csaba Polgar, MD, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomized, phase 3, non-inferiority trial. GEC-ESTRO The Lancet, October 2015

Documents

Discover more about SAVI Brachy by reviewing the brochures and Instructions for Use.

Order Information

View All Details